Other News

Qardio announces the first Remote Patient Monitoring system to include a Cardiac monitoring service in a single, intuitive platform.

SAN FRANCISCO, Sept. 14, 2021 /PRNewswire/ — Qardio, Inc. announced today the launch of the first ever fully remote end-to-end RPM service to include cardiac arrhythmia analysis. QardioDirect (Qardio’s all-inclusive service for RPM) now includes ambulatory Cardiac monitoring to help diagnose atrial fibrillation along with a large range of other arrhythmias. Multiple […]

Novocardia™ Enters Into Partnership with MedAxiom™

Strategic Alliance Focused on Promoting Common Mission of Transforming Quality, Value, and Outcomes of Cardiovascular Care NEW YORK, Sept. 14, 2021 /PRNewswire/ — Novocardia, a value-based cardiovascular disease care delivery platform, and MedAxiom, the cardiovascular community’s premier source for organizational performance solutions, today announced the formation of a strategic industry partnership. The partnership […]

Boston Children’s Hospital announces $20 million gift to advance treatment of pediatric heart disease

BOSTON, Sept. 14, 2021 /PRNewswire/ — Boston Children’s Hospital today announced a $20 million gift from the Benderson Family Foundation to fuel the next generation of discoveries in the treatment of pediatric heart disease. In recognition of this gift, the hospital is honored to rename its combined cardiovascular programs the Benderson Family Heart Center […]

HeartFlow Holding, Inc. Provides Selected Preliminary Second Quarter 2021 Financial Results and Updated Guidance for Full Year 2021

REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow Holding, Inc. (“HeartFlow” or the “Company”), the leader in revolutionizing precision heart care, today announced selected preliminary financial results for the period ended June 30, 2021 and provided updated guidance for the year ending December 31, 2021. Financial Highlights Revenue for the second quarter of 2021 was […]

Vibrato Medical Closes $4M Series A Funding Round and Receives $1.5M NIH Grant

Funds will support the company’s mission of advancing noninvasive treatment options for people with reduced tissue perfusion IRVINE, Calif.–(BUSINESS WIRE)–Vibrato Medical, an innovator in the treatment of peripheral arterial disease (PAD), announced today that it has closed a $4M Series A funding round led by the Horowitz Group, a multi-asset […]

CardioFocus Announces Agreement to Acquire Intellectual Property

MARLBOROUGH, Mass., September 14, 2021 – CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has entered into an agreement with IsoLase Ltd. to acquire IsoLase’s patent portfolio. The acquisition agreement includes US patents 8,992,514 and 10,517,669 and EU patent […]

Sensome Begins Human Trial for Its AI-Powered Stroke Guidewire

PARIS–(BUSINESS WIRE)–Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today that Gold Coast University Hospital (GCUH) in Australia enrolled the first patients in the Company’s CLOT OUT first-in-human study evaluating safety and performance of the Clotild® Smart Guidewire System in large-vessel acute […]

DiaMedica Therapeutics Initiates Pivotal Trial of DM199 for the Treatment of Acute Ischemic Stroke

 The ReMEDy2 Trial Will Assess the Potential of DM199 to Both Improve Recovery After a Stroke and Prevent Stroke Recurrence Opportunity to Expand Therapeutic Treatment Window and Eligible Patient Population for Acute Ischemic Stroke for the First Time in Decades MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company […]

iRhythm® Technologies Names Quentin Blackford President and Chief Executive Officer

Accomplished MedTech Leader with Proven Track Record of Strategic, Operational and Financial Execution with High Growth Companies SAN FRANCISCO, Sept. 13, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Quentin Blackford has […]

ZOLL Medical Corporation Signs Definitive Agreement to Acquire Itamar Medical

Acquiring provider of home sleep apnea diagnosis solutions will allow ZOLL to better serve undiagnosed and untreated cardiac patients CHELMSFORD, Mass. & CAESAREA, Israel–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Itamar™ Medical Ltd. (Nasdaq and TASE: ITMR), a medical device and […]